• CTSU C80702: A Phase III Trial of 6 versus 12 treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for patients with Resected Stage III Colon Cancer

Esophageal/GE Junction

  • SWOG S1201: Combination Chemotherapy in Treating Patients With Advanced or Metastatic Esophageal Cancer, Gastric Cancer, or Gastroesophageal Junction Cancer
  • RTOG 1010A Phase II Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma.


  • N1048:   Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery




For more information, contact Cheryl Patz, RN, OCN, CCRC, at 360- 788-8238.​​​​​